Inspec

Inspec Gross Margin

The Gross Margin of Inspec (6656.T) as of Nov 13, 2026 is 33.91 %. In the previous year, Gross Margin was 40.02 % — a change of -15.27% (lower).

Gross Margin

33.91 %

YoY

-15.27%

Last updated:

Gross Margin of Inspec is 2026 33.91 % . Gross Margin of Inspec was 2025 40.02 % . It decreases by -15.27% lower compared to the previous year.

Inspec's gross margin stands at 33.9%, down from 37.0% several years earlier.

The Inspec Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
40.62 JPY
Jan 1, 2020
38.56 JPY
Jan 1, 2021
34.96 JPY
Jan 1, 2022
36.97 JPY
Jan 1, 2023
35.93 JPY
Jan 1, 2024
35.77 JPY
Jan 1, 2025
40.02 JPY
Jan 1, 2026
33.91 JPY
The Inspec Gross Margin history
YEARGross MarginYoY
33.91 %-15.27%
40.02 %+11.88%
35.77 %-0.44%
35.93 %-2.84%
36.97 %+5.78%
34.96 %-9.35%
38.56 %-5.07%
40.62 %+17.82%
34.48 %-19.59%
42.87 %+4.19%
41.15 %+10.31%
37.30 %-9.09%
41.04 %+18,365.02%
0.22 %-29.43%
0.31 %-26.60%
0.43 %+214.98%
0.14 %-121.24%
-0.64 %-336.29%
0.27 %+4.78%
0.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

Gross Margin of Inspec is 33.91 % in 2026.

Gross Margin of Inspec changed from 40.02 % to 33.91 %, representing a -15.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Inspec since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Inspec with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Inspec

All Key Metrics — Inspec